iCAD, INC. (NASDAQ:ICAD) Files An 8-K Other Events
Item 8.01. Other Events.

In December 2016, the members of iCAD’s Board of Directors (the “Board”) agreed that they will receive stock options or restricted stock in lieu of the cash payments to which they would otherwise have been entitled for director services for 2017.

About iCAD, INC. (NASDAQ:ICAD)

iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. It develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.

iCAD, INC. (NASDAQ:ICAD) Recent Trading Information

iCAD, INC. (NASDAQ:ICAD) closed its last trading session 00.00 at 3.23 with 6,324 shares trading hands.